Predicting liver recovery with spleen stiffness and blood tests
Part of Digestive system, Infections clinical trials.
This study uses a simple, non-invasive ultrasound test of your spleen and routine blood tests to see if your liver can start working better after treatment. It is for people whose cirrhosis has recently caused complications but who are now doing well on treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- Have been diagnosed with cirrhosis that has recently caused a complication like fluid in the belly or bleeding (in the last year or not in the past year if you have a history of it)
- Be on effective treatment for the cause of your cirrhosis — for example, antiviral medicine for hepatitis B, or staying away from alcohol for at least 2 months if alcohol caused your cirrhosis
- Not have had a liver transplant, a procedure called TIPS, or spleen surgery
- Not have liver cancer, a blocked vein in your liver, or other cancers (except those cured)
- Not be pregnant or breastfeeding, and have no severe heart, lung, kidney, or mental health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a simple ultrasound test (measuring liver and spleen stiffness) to predict if a patient with cirrhosis and advanced liver cancer has enlarged veins in the esophagus. The goal is to avoid unnecessary invasive procedures like endoscopy.
This study looks at how well a simple score (called SSM) can predict recovery in people with chronic liver disease who suddenly get a liver injury with jaundice. It may help your doctors understand how serious your condition is.
This study looks at people over 18 who have advanced, long-term liver scarring. It uses specialized measurements of liver stiffness and pressure to confirm eligibility and may help doctors better understand this condition.
This study is building a model to better predict how metabolic liver disease (MASLD) that has led to cirrhosis (scarring of the liver) will progress. If you have compensated cirrhosis (your liver is still working well) and have been diagnosed with MASLD or a related condition, this research could help develop more personalized care.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
This study looks at new blood markers to better predict recovery in patients hospitalized for complications of cirrhosis (like fluid buildup, confusion, or bleeding). You may qualify if you were recently hospitalized for these issues and are expected to go home soon.
Hear when a new Decompensated Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.